Preventive Treatment in Migraine Today

Migraine Resources published on October 15, 2018
Deborah I. Friedman, MD, MPH, FAAN
Professor of Neurology & Neurotherapeutics and Ophthalmology
University of Texas Southwestern Medical Center
Dallas, Texas

According to current estimates, about 1 in 6 Americans suffers from highly disabling migraine headaches, with women, children, adolescents, and underserved populations representing a significant proportion of these individuals. This figure is likely lower than what has been reported considering that few people with migraine are aware of or report their condition. In a recent satellite symposium held at this year’s American Headache Society meeting and hosted by Emerging Solutions in Pain, Dr. Deborah Friedman described the scope of migraine in the United States and its common misdiagnoses. She also discussed poor adherence to preventive medication and other factors that may impact how migraine is viewed and treated.

Download Slides
Provided by MediCom Worldwide, Inc.
Supported by an educational grant from Teva Pharmaceuticals
Last modified: December 10, 2019